Ghent University Academic Bibliography

Journal Article
A1
open access

Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L. Siu, Patricia LoRusso, Claire F. Friedman, Ani S. Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey (UGent) , et al.

(2025) NATURE MEDICINE. 31(1). p.152-164

Add to list

Journal Article
A1
open access

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

Areeba Patel, Kirsten Göbel, Sebastian Ille, Felix Hinz, Natalie Schoebe, Henri Bogumil, Jochen Meyer, Michelle Brehm, Helin Kardo, Daniel Schrimpf, et al.

(2025) NATURE MEDICINE. 31. p.1567-1577

Add to list

Women’s health and rights in the twenty-first century

Samuel Akombeng Ojong, Marleen Temmerman (UGent) , Rajat Khosla and Flavia Bustreo

(2024) NATURE MEDICINE. 30(6). p.1547-1555

Add to list

Journal Article
A1
open access

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer : a phase 2 adaptive trial

Iris Nederlof, Olga I. Isaeva, Manon de Graaf, Robbert C. A. M. Gielen, Noor A. M. Bakker, Adrianne L. Rolfes, Hannah Garner, Bram Boeckx, Joleen J. H. Traets, Ingrid A. M. Mandjes, et al.

(2024) NATURE MEDICINE. 30(11). p.3223-3235

Add to list

Journal Article
A1
open access

High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity

Sohyon Lee, Tobias Weiss, Marcel Bühler (UGent) , Julien Mena, Zuzanna Lottenbach, Rebekka Wegmann, Miaomiao Sun, Michel Bihl, Bartłomiej Augustynek, Sven P. Baumann, et al.

(2024) NATURE MEDICINE. 30(11). p.3196-3208

Add to list

Journal Article
A1
open access

RANKL blockade for erosive hand osteoarthritis : a randomized placebo-controlled phase 2a trial

Ruth Wittoek (UGent) , Gust Verbruggen, Tine Vanhaverbeke (UGent) , Roos Colman (UGent) and Dirk Elewaut (UGent)

(2024) NATURE MEDICINE. 30(3). p.829-836

Add to list

An EU task force to assess the burden of rare diseases

Pavel Kolkhir, Diana Alecsandra Grad, Periklis Charalampous, Claudia Cruz Oliveira, Enkeleint A. Mechili, Brigid Unim, David A. Pearce, Marcus Maurer, Brecht Devleesschauwer (UGent) and Juanita Haagsma

(2023) NATURE MEDICINE. 29(3). p.516-517

Add to list

Journal Article
A1
open access

In-depth virological and immunological characterization of HIV-1 cure after CCR5 Delta 32/Delta 32 allogeneic hematopoietic stem cell transplantation

Bjoern-Erik Ole Jensen, Elena Knops, Leon Cords, Nadine Luebke, Maria Salgado, Kathleen Busman-Sahay, Jacob D. D. Estes, Laura E. P. Huyveneers, Federico Perdomo-Celis, Melanie Wittner, et al.

(2023) NATURE MEDICINE. 29(3). p.583-587

Add to list

Journal Article
A1
open access

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

[missing] NCD Risk Factor Collaboration (NCD-RisC), Bin Zhou, Kate E. Sheffer, James E. Bennett, Edward W. Gregg, Goodarz Danaei, Rosie K. Singleton, Jonathan E. Shaw, Anu Mishra, Victor P. F. Lhoste, et al.

(2023) NATURE MEDICINE. 29. p.2885-2901

Add to list

BrainStorm : a multicenter international study to tackle CNS metastases in solid tumors

Diogo Martins-Branco, Guilherme Nader-Marta, Andrea Gombos, Philippe Barthelemy, Anthony Goncalves, Edith Borcoman, Florian Clatot, Stephane Holbrechts, Eleonora De Maio D’Esposito, Claire Cheymol, et al.

(2023) NATURE MEDICINE. 29. p.2981-2982

Academic Bibliography

Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

Women’s health and rights in the twenty-first century

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer : a phase 2 adaptive trial

High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity

RANKL blockade for erosive hand osteoarthritis : a randomized placebo-controlled phase 2a trial

An EU task force to assess the burden of rare diseases

In-depth virological and immunological characterization of HIV-1 cure after CCR5 Delta 32/Delta 32 allogeneic hematopoietic stem cell transplantation

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

BrainStorm : a multicenter international study to tackle CNS metastases in solid tumors

Contents

Support

Contact